Tax Considerations in Reducing Concentrated Stock Positions

Assume the investment decision has already been made.

An investor owns $5 million of one company’s stock and has determined that the position should be reduced to $2 million. The remaining question is how to sell or transfer $3 million of stock without creating more tax than necessary.

That is a narrower problem than deciding whether the position is too concentrated. It is also more measurable.

Different shares of the same company can have very different tax costs. Capital-loss carryforwards can create temporary capacity to recognize gains efficiently. A sale spread over several years may reduce rates for one taxpayer and accomplish little more than tax deferral for another. Existing charitable commitments can remove highly appreciated shares without requiring the investor to realize the embedded gain personally.

The objective is not to minimize this year’s tax bill. It is to reach the desired portfolio with the lowest sensible after-tax cost.

Scope of the Analysis

This framework applies primarily to concentrated stock held in a taxable account after the decision to reduce the position has been made.

Employer securities inside a qualified retirement plan require a separate analysis because net unrealized appreciation rules may apply. Private-company shares that may qualify under Section 1202 also require a different framework because an exclusion can dominate the ordinary capital-gain analysis.

For ordinary taxable stock, however, the starting point is straightforward: determine exactly what is being sold.

Tax Lot Economics

Consider a $5 million position consisting of three long-term tax lots:

Lot

Market Value

Tax Basis

Embedded Gain

Gain as % of Value

A

$1.0M

$950K

$50K

5%

B

$1.5M

$900K

$600K

40%

C

$2.5M

$250K

$2.25M

90%

Total

$5.0M

$2.10M

$2.90M

The family wants to reduce the position by $3 million.

If the custodian simply treats the stock as one economic position, the tax cost can be substantially higher than necessary. The investor does not own one $5 million tax asset. The investor owns several lots with different embedded liabilities.

Specific identification generally allows a taxpayer to use the basis of the particular shares sold when those shares are adequately identified with the broker. If the shares cannot be adequately identified, FIFO generally determines which shares are treated as sold.

That makes lot selection part of portfolio implementation rather than an administrative detail.

Marginal Tax Cost

Assume for illustration that all three lots receive long-term treatment and the investor is subject to a 20% federal long-term capital-gain rate plus the 3.8% Net Investment Income Tax on the relevant gain.

NIIT is actually imposed at 3.8% on the lesser of net investment income or MAGI above the applicable statutory threshold, so 23.8% should not be treated as a universal capital-gain rate.

The tax cost of selling each lot is very different:

Lot

Gain per $1 of Stock Sold

Illustrative Federal Tax per $1 Sold

A

$0.05

$0.012

B

$0.40

$0.095

C

$0.90

$0.214

Every dollar sold removes one dollar of company-specific exposure. The immediate federal tax cost ranges from approximately one cent to more than twenty-one cents per dollar of exposure removed.

We think that is a more useful way to evaluate the sale sequence: what is the marginal tax cost of removing the next dollar of concentration?

Now apply it to the family’s $3 million reduction.

Selling all of Lot A and Lot B removes $2.5 million of stock while realizing $650,000 of gain. The remaining $500,000 reduction can come from Lot C. Because 90% of Lot C’s value represents embedded gain on these simplified facts, that sale realizes another $450,000.

The family therefore removes $3 million of exposure while realizing approximately $1.1 million of gain.

At an illustrative 23.8% federal rate, the current federal tax would be approximately $261,800.

Now compare that with a sale that effectively removes the same $3 million proportionately across the entire position. Sixty percent of the position is sold, along with sixty percent of its $2.9 million embedded gain. Approximately $1.74 million of gain would be realized, producing roughly $414,000 of illustrative federal tax.

The investment result is the same: $3 million of company stock has been removed.

The immediate federal tax difference is more than $150,000.

That is why the sale instruction should not simply be a dollar amount.

Tax Cost and Sale Sequencing

The higher-basis lots will often be the logical place to begin, but lowest current tax should not become an absolute rule.

Suppose the family has already sold Lots A and B and still wants to reduce the position further. The next $1 million sold from Lot C would realize approximately $900,000 of gain.

At the same illustrative federal rate, that creates approximately $214,200 of current federal tax.

At that point the marginal cost of additional diversification has risen substantially.

That is useful information, but it does not mean the investor should stop.

The question becomes whether preserving the tax deferral on that $1 million block is worth continuing to own the associated company-specific exposure. If the shares were likely to be sold eventually anyway, the economic cost of selling today is not necessarily equal to the face amount of the tax check. Part of the cost is accelerating a liability that otherwise could have remained deferred.

Different conclusions may apply when the shares are realistically expected to be donated, transferred through an estate, or otherwise subject to materially different future tax treatment.

The disposition schedule should therefore reflect both the current tax generated and the realistic future tax alternative.

Using Capital Loss Carryforwards

Capital losses can materially lower the marginal tax cost of a particular stage of the reduction.

Assume the family has a $500,000 capital-loss carryforward.

That does not mean the family should sell $500,000 of stock. Capital losses offset capital gains under the applicable netting rules. The useful question is how much stock can be sold while generating approximately $500,000 of gain.

Using Lot C, where 90% of the market value represents embedded gain, approximately $556,000 of stock would have to be sold to realize roughly $500,000 of gain.

Using Lot B, where only 40% of the value represents gain, approximately $1.25 million of stock could be sold to generate the same $500,000 of gain.

The same loss carryforward can therefore support very different amounts of portfolio reduction depending on the lots being sold.

That does not mean the loss should always be paired with the lowest-basis shares. If higher-basis shares can already be sold at very low cost, preserving losses for a more tax-expensive stage of the liquidation may be more valuable.

Capital losses should be incorporated into the sequence, not simply netted against whatever gains happened to occur during the year.

Timing Across Tax Years

A multi-year sale schedule should be modeled rather than assumed to reduce taxes.

Consider an investor who expects taxable income to remain comfortably inside the highest long-term capital-gain bracket and MAGI to remain above the NIIT threshold for the next four years.

Selling $4 million of gain in one year versus $1 million in each of four years may change the timing of the tax materially without changing the marginal federal rate on most of the gain.

The benefit of spreading the sale is much larger when something actually changes between years.

A future year may have lower earned income. The investor may retire. Existing loss carryforwards may become available. A genuine change in state residency may alter state taxation. Large charitable deductions may be planned. Other significant gains may disappear from the return.

Without one of those differences, a multi-year strategy may primarily represent continued tax deferral.

That deferral has value. It should simply be valued as deferral rather than described as a lower tax rate.

Meanwhile, every year added to the schedule leaves part of the original concentration in place.

The analysis should therefore compare the tax benefit of waiting with the amount of exposure that remains outstanding.

Charitable Contributions

Existing charitable commitments can change which shares should be sold.

Assume a family intends to contribute $250,000 to charity this year regardless of the concentrated-stock decision.

Selling $250,000 of highly appreciated shares, paying the capital-gain tax, and then contributing $250,000 of cash uses more tax capacity than necessary.

Long-term appreciated securities contributed directly to a qualifying charitable organization can generally be deductible at fair market value, subject to the applicable deduction limitations and other requirements. Contributions of capital-gain property using fair market value can be subject to a 30% of AGI limit in common circumstances.

For a family with an existing $250,000 charitable commitment, the lowest-basis long-term shares may therefore be more valuable as charitable property than as sale candidates.

Return to Lot C. A $250,000 contribution from that lot contains approximately $225,000 of embedded gain.

Using the same illustrative 23.8% federal rate, selling those shares first could create approximately $53,550 of federal capital-gain tax before the charitable contribution is even made.

Contributing the shares directly removes the same $250,000 of company exposure without requiring the family to realize that embedded gain personally, while the charitable deduction is governed separately by the applicable rules and limits.

That is not a reason to give more money to charity.

It is a reason to use the most tax-efficient asset to fund giving the family already intended to do.

An Integrated Sale Sequence

For the $5 million position in our example, the implementation analysis might look like this:

Stage

Available Action

Tax Consideration

Initial reduction

Sell high-basis long-term shares

Low gain per dollar of exposure removed

Existing losses

Realize gains against usable capital-loss capacity

Reduces marginal current tax on selected sales

Planned charitable giving

Contribute appropriate low-basis long-term shares

Removes exposure without personally realizing embedded gain

Remaining low-basis stock

Compare current sale with future sale years

Measures value of continued tax deferral

Final execution

Specify tax lots with custodian

Prevents default lot selection from changing intended result

The sequence should be built around the family’s actual holdings and tax return.

A client with no charitable intent would skip that component. A client without loss carryforwards would have less low-tax capacity. Someone approaching retirement may have a future low-income year worth waiting for. Another investor may have enough concentration risk that immediate diversification is worth paying the current tax.

The analysis should change when those facts change.

Measuring the Entire Reduction

The final output should reconcile the full desired liquidation rather than optimize each trade independently.

Assume again that the investor wants to move from $5 million to $2 million.

We would want to know how much of the $3 million reduction can be accomplished through high-basis sales, how much gain can be absorbed by existing capital losses, how much already-planned charitable giving can be funded with appreciated shares, and what embedded gain remains in the stock that still needs to be sold.

Only then would we compare sale years for the remaining balance.

The useful output is not simply projected tax by year. It is a schedule showing:

Measure

Result

Starting concentrated position

$5.0M

Target position

$2.0M

Required exposure reduction

$3.0M

Stock sold by tax-lot category

Actual

Stock transferred charitably

Actual

Capital gain realized

Actual

Loss carryforwards used

Actual

Current federal and state tax

Projected

Remaining embedded gain

Actual

Remaining concentrated exposure

$2.0M

That makes the tradeoff visible.

The family can see both what it accomplished and what it cost.

Separate Analyses for Special Tax Regimes

Two types of company stock should be removed from this framework before the liquidation schedule is built.

Employer stock held inside a qualified retirement plan may qualify for net unrealized appreciation treatment. A rollover to an IRA can materially change that opportunity, so NUA should be evaluated separately before the shares are moved.

Private-company stock that may qualify under Section 1202 also requires its own analysis. The potential federal exclusion can be large enough that ordinary tax-lot sequencing is secondary to establishing whether the shares qualify, which statutory regime applies, and whether an important holding-period threshold is approaching.

Those are separate tax problems.

Combining them into a general concentrated-stock strategy makes the analysis less precise rather than more comprehensive.

Conclusion

Once the decision to reduce a concentrated stock position has been made, the implementation problem is measurable.

Different tax lots can impose dramatically different current tax costs for the same amount of risk reduction. Capital-loss carryforwards can create temporary capacity to realize gains efficiently. Planned charitable contributions can remove highly appreciated shares without first converting them to cash. Multi-year sales can be valuable when the family’s tax circumstances actually change between years, but may provide little more than deferral when they do not.

The relevant measure is the tax cost associated with each additional dollar of concentration removed.

That cost will usually rise as the easiest tax lots and available tax capacity are exhausted.

The objective is not to stop selling when the tax becomes uncomfortable. It is to understand the cost curve before execution begins, then determine which parts of the reduction should occur now and which, if any, should occur later.

That produces a disposition plan built around the portfolio the family has already decided it wants to own.

Frequently Asked Questions

Which shares should be sold first?

There is no universal order. Higher-basis long-term shares often create less current tax per dollar of stock sold, but existing capital losses, charitable plans, holding periods, state taxation, and the expected timing of future sales can change the optimal sequence. Specific identification with the broker is important when particular lots are intended to be sold.

Does spreading a concentrated-stock sale over several years always reduce taxes?

No. If the investor remains subject to the same capital-gain rate and NIIT treatment each year, a multi-year schedule may primarily defer the tax rather than reduce its marginal federal rate. The benefit should be calculated using projected income and tax circumstances for each year. NIIT applies at 3.8% under its own income and MAGI rules.

Should appreciated shares be donated instead of sold?

Only when the family already intends to make the charitable contribution. Long-term appreciated property can often be an efficient asset to contribute because the donor generally does not first realize the embedded capital gain, while the charitable deduction remains subject to the applicable valuation, AGI, and other limitations.

About Croak Capital

Croak Capital is a wealth management firm serving individuals and families nationwide. We help clients make major financial decisions, manage their capital, and coordinate the investment, tax, estate, and planning work around their lives.

This article is for informational purposes only and does not constitute tax, legal or investment advice. Tax treatment depends on the security, tax lots, holding periods, income, charitable activity, state law, account ownership, and taxpayer circumstances.